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This study was designed to develop an in situ histochemical heme staining method for an intact 
animal using the free-living nematode Caenorhabditis elegans.  Although, heme is vital to many 
biological processes and synthesized by most known free-living organisms, C. elegans is a 
natural heme auxotroph. Using the substrate 3-3’ diaminobenzidine and hydrogen peroxide, we 
used C. elegans to study the fate of heme.  We found a direct correlation between heme in the 
growth medium and the organismal heme content.  In addition, our studies confirmed that 
parents exposed to different heme levels contribute varying maternal heme to their progeny. 
Moreover, this methodology detected differences in heme levels between wild-type and mutants 
in heme homeostasis.  Finally, we provide preliminary evidence that the technique can be applied 
to analyze heme-based structures at the electron microscopy level.  Our studies described herein 
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Chapter 1: Literature Review 
Introduction 
The porphyrin, heme is one of the most biologically diversified molecules in 
nature.  Heme functions as a prosthetic group in hundreds of proteins including the 
globins, respiratory cytochromes, cytochrome P450s, and thyroperoxidases, all 
proteins vital to processes such as oxygen transport, xenobiotic detoxification, 
oxidative metabolism, and thyroid hormone synthesis (1).  In addition to functioning 
as a prosthetic group for a wide variety of proteins, heme also directly regulates 
biological processes such as cellular differentiation, cell cycle progression, and gene 
regulation (2,3).  Most eukaryotes and prokaryotes synthesize heme in a highly 
conserved eight-step biosynthetic pathway.  Regulation of heme biosynthesis has 
been extensively studied in many organisms including bacteria, yeast, and mammals 
(4-6). In humans, a deficiency in any of the enzymes of the heme biosynthetic 
pathway can lead to diseases known as the porphyrias.  
There is a considerable amount of information known about eukaryotic heme 
biosynthesis and the wide-range of heme’s functions in eukaryotes, however, very 
little is known about how this molecule is transported into cells, within cells, and into 
cellular organelles.  While there have been studies that traced heme absorption in 
mammalian intestinal cells (7,8), only recently has research begun to identify proteins 
involved in eukaryotic heme uptake and transport (9-12).  Once heme is synthesized 





hemoproteins.  The rest of the newly synthesized heme must be transported out of the 
mitochondria for incorporation into hemoproteins located in the cytosol, nucleus, 
endoplasmic reticulum, and other organelles in order to participate in various cellular 
processes.  Heme is hydrophobic and cytotoxic and can cause extensive cellular 
damage due to its inherent peroxidase activity.  Thus, a prima facie argument can be 
made that heme likely does not exist free in cells.  Understanding the fundamental 
biological process of eukaryotic heme trafficking has wide-ranging implications for 
solving pressing human, livestock, and crop health issues.  From a human nutritional 
standpoint, dietary heme is the most bioavailable form of iron, but the heme 
absorption pathway(s) into intestinal cells is unknown.  From a disease standpoint, 
helminthic infections are a tremendous burden to humans and livestock.  Recent 
research indicates that several species of infectious nematodes are heme auxotrophs, 
i.e. they cannot synthesize heme but acquire it from diet (13).  Discovery of heme 
transport pathway genes unique to these helminths could lead to the development of 
new pharmaceuticals to control helminthic infections.  
Several techniques have been developed to cytologically localize heme and 
characterize its absorption into and transport within cells.  Many methods involve the 
use of fluorescent dyes (14), fluorescent heme analogs (15), and radioisotopes (16), 
but one well-established method can be used to directly stain heme.  This staining 
method involves the use of the compound 3-3’ diaminobenzidine (DAB) and exploits 
the peroxidase activity of heme to generate a localized reaction product (17).  
Unpublished results have established that the non-parasitic nematode C. elegans is a 





uptake (13).  Establishment and examination of staining whole animals, such as C. 
elegans, for heme will provide a new approach to expand current knowledge of 
organismal heme homeostasis.  
Heme biosynthesis 
Heme biosynthesis occurs in a complex eight-step pathway conserved 
between eukaryotes and prokaryotes and can be broken down into several key 
processes (18).  Briefly, a pyrrole ring is formed by two molecules of δ-
aminolevulinic acid (ALA), followed by their assembly into a tetrapyrrole.  
Protoporphyrinogen IX is then formed by modification of the tetrapyrrole side chain 
and is subsequently oxidized to protoporphyrin IX.  Iron is inserted into 
protoporphyrin IX in the final step to form protoheme, or heme b, the most common 
form of heme (18).  Depending upon the hemoprotein for which heme is needed, 
heme b can then be modified to heme a or heme c.   
The first step in eukaryotic heme biosynthesis occurs in the mitochondria and 
results in the formation of ALA, the universal porphyrin precursor, by a condensation 
reaction between succinyl CoA and glycine catalyzed by ALA synthase (ALAS), as 
seen in Figure 1.  ALA is then transported out of the mitochondria into the cytoplasm.  
In the second step, two molecules of ALA form porphobilinogen in a condensation 
reaction catalyzed by aminolevulinic acid dehydratase, also known as 
porphobilinogen synthase.  Four molecules of porphobilinogen are then used to form 
the unstable polymer hydroxymethylbilane in the third reaction catalyzed by 





Figure 1: Eukaryotic heme biosynthetic pathway. 
The eight-step eukaryotic heme biosynthetic pathway begins with the synthesis of 
ALA in the mitochondria.  ALA is then transported from the mitochondria into the 
cytosol, where the subsequent four steps occur.  The heme precursor 
coproporphyrinogen III is transported back into the mitochondria for the final three 









































hydroxymethylbilane to uroporphyrinogen III during step four.  Step five involves the 
conversion of uroporphyrinogen III to coproporphyrinogen III catalyzed by 
uroporphyrinogen decarboxylase.  Coproporphyrinogen III is then transported back 
into the mitochondria where coproporphyrinogen oxidase, an enzyme located in the 
mitochondrial inner membrane, catalyzes the formation of protoporphyrinogen IX 
during step six.  Next, protoporphyrin IX is formed by protoporphyrinogen oxidase.  
The final step occurs when ferrous iron is inserted into the protoporphyrin IX cyclic 
macromolecule to form heme b.  This final reaction is catalyzed by ferrochelatase.  
Further modifications of heme b at C-2 and C-8 are required to form heme a, the form 
of heme found in cytochrome oxidases (19).  Synthesis of heme a from heme b 
involves two enzymatic reactions.  Heme O synthase catalyzes the conversion of the 
vinyl group to a 17-hydroxyethylfarnesyl to generate heme o.  Heme o is then 
converted to heme a by heme A synthase (HAS) (20).  Heme c is found in 
cytochromes c1 and c and differs from heme b in that heme c covalently binds to its 
proteins through the two vinyl side chains (21). 
  While this biosynthetic pathway is highly conserved between eukaryotes and 
prokaryotes, there are a few differences.  One obvious difference is that, in 
eukaryotes, the biosynthetic pathway is partially compartmentalized between the 
mitochondria and the cytosol, as demonstrated in Figure 1.  Another difference is that 
some prokaryotes can synthesize ALA by an alternative pathway.  These organisms 
synthesize ALA via the C-5 pathway, a pathway that converts glutamic acid to ALA 
acid glutamyl-tRNA and glutamate semialdehyde as intermediates (22).  No known 





ALAS pathway.  One other notable difference between eukaryotes and prokaryotes is 
that eukaryotic heme demand requires heme to be both exogenously acquired as well 
as endogenously synthesized, while prokaryotic heme demand is usually met by heme 
biosynthesis (23). 
Regulation of heme biosynthesis  
Regulation of heme biosynthesis has been studied in many different model 
systems and varies from organism to organism.  In some organisms, heme 
biosynthesis is connected to iron availability (4,18), while, in others, regulation can 
depend on oxygen levels (5).  In the yeast Schizosaccharomyces pombe, Sterol 
Regulatory element binding protein (Sre1p) up-regulates six heme biosynthetic 
pathway enzymes during anaerobic conditions (5).  It is thought that Sre1p maintains 
heme levels under oxygen-limiting conditions.  
In the bacterium Bradyrhizobium japonicum, heme biosynthesis is 
coordinated to iron availability (4).  Iron is inserted in the protoporphyrin IX ring by 
ferrochelatase during the final step of the heme biosynthetic pathway.  During iron 
deficiency, bacterial cells with a mutation in the iron response regulator (IRR) gene 
are unable to arrest the heme biosynthetic pathway and accumulate toxic levels of 
protoporphyrin IX.  This protein coordinates heme biosynthesis to iron availability.  
Additional studies showed that IRR inhibits the heme biosynthetic pathway by 
inhibiting hemB, the gene encoding ALA dehydratase in B. japonicum.  Under iron 
limiting conditions, IRR inhibition of hemB ultimately prevents toxic accumulation of 





In mammals, it is the first step of heme biosynthesis, catalyzed by the enzyme 
ALAS, that is highly regulated.  Mammals differ from other organisms in that they 
require two different forms of ALAS.  While heme biosynthesis occurs in every cell, 
the majority of heme biosynthesis occurs in the bone marrow for incorporation into 
hemoglobin.  This increased demand for heme biosynthesis in the bone marrow 
requires a separate form of ALAS, ALAS2. ALAS2 is expressed only in erythroid 
cells, in the bone marrow (24), while ALAS1 encodes the constitutively expressed 
form of ALAS.  Regulation of heme biosynthesis in erythroid cells via ALAS2 is thus 
separate from regulation of constitutive biosynthesis at the level of ALAS1 (18).  
In mammals, the main transcriptional regulator of ALAS1 is neuronal Pas 
domain protein 2 (NPAS2), a mammalian transcription factor known to be part of the 
core circadian clock mechanism (6).  NPAS2 is a PAS domain protein, a family of 
proteins that can detect environmental signals such as oxygen and light, as well as 
small aromatic molecules, including heme (25).  NPAS2 has two PAS domains, each 
of which bind heme, and the ability of NPAS2 to bind DNA is dependent on heme 
availability.  When NPAS2 binds heme, it forms a heterodimer with BMAL1, and this 
transcription complex binds the ALAS1 promoter.  Expression of ALAS1 is then 
upregulated, thus inducing heme biosynthesis (6).  Excess heme in the cell induces 
heme oxygenase, the enzyme responsible for degrading heme into carbon monoxide, 
biliverdin, and iron.  In the presence of carbon monoxide, the NPAS2 –BMAL1 
transcription complex cannot sufficiently bind DNA, thus preventing expression of 
ALAS1 (25).  





acetyltransferase p300 (26).  This transcriptional regulator is recruited by the 
erythroid specific transcription factor, GATA1.  The interaction of these two proteins 
activates the ALAS2 promoter (27).  Translational regulation of ALAS2 in murine 
erythroleukemia cells is regulated in an iron–dependent manner by the Iron 
Responsive Element/ Iron Responsive Protein (IRE/IRP) system (28).  When iron is 
low, IRP binds to the IRE of the 5’ untranslated region of the ALAS2 mRNA 
transcript, inhibits translation and prevents heme synthesis in these erythroid cells.  
While IRP exists in two forms, IRP1 and IRP2, only IRP2 translationally regulates 
ALAS2 (29).  IRP2 knockout mice overexpress ALAS2 and have elevated levels of 
free protoporphyrin IX in their red blood cells, which is possibly responsible for 
observed phenotypes that include photosensitivity, skin and eye lesions (29).   
Deficiencies in heme biosynthesis 
 Any deficiency in ALAS2 or the other seven enzymes in this pathway can 
cause the porphyrias.  Porphyrias are a family of diseases that cause neuropsychiatric 
symptoms including anxiety, insomnia, confusion, hallucinations, agitation and 
paranoia (30).  Porphyria attacks could occur because a) heme deficiency leads to 
deficiency of hemoproteins critical to cellular function, or b) enzyme defects cause 
toxic levels of pathway intermediates to accumulate, resulting in a neurotoxic effect 
(30).  An additional explanation is that heme deficiency results in decreased 
production of microRNAs, a class of RNAs vital to many diverse biological 
processes.  Recently, microRNA processing was shown to involve heme (3).  Heme 






Once heme is endogenously synthesized or exogenously acquired, it must then 
be transported to the cytoplasm or cellular organelles for insertion into any of the 
hemoproteins vital to cellular function.  The cytochrome P450 enzymes are 
hemoproteins whose primary role is xenobiotic detoxification.  Xenobiotics are 
foreign chemicals found in an organism that must be safely metabolized and excreted. 
Food additives, industrial chemicals, pesticides, plant toxins and pharmaceutical 
agents are common xenobiotics.  Deamination, desulfuration, hydroxylation, and 
oxidation reactions catalyzed by cytochrome P450s allow cells to metabolize 
xenobiotics into a form that can be excreted (31).  In yeast and humans, cytochrome 
P450s are required for sterol biosynthesis.  It was discovered recently that the 
eukaryotic hemoprotein Dap1 binds several endoplasmic reticulum cytochrome P450 
proteins in both humans and yeast and that Dap1 is essential for sterol biosynthesis 
(32).   
Another family of hemoproteins is the heme-based sensor family.  These 
proteins are key regulators of adaptive responses to changing levels of oxygen, 
carbon monoxide, and nitric oxide.  Proteins are classified as heme-based sensors 
because one protein domain is controlled by a heme-binding domain within the same 
protein (25).  There have been more than fifty heme-based sensors studied in bacteria 
and mammalian cells (26).  One example of a mammalian heme-based sensor is 
soluble guanylyl cyclase. This cytosolic protein synthesizes cyclic guanosine 





nitrous oxide and carbon monoxide.  cGMP then acts on downstream effectors that 
control smooth muscle tone and neurotransmission among other physiological 
processes (26).  
Heme is vital to cellular respiration because several key hemoproteins are 
involved in energy production (1).  These hemoproteins are the respiratory 
cytochromes, electron-transferring proteins located in the mitochondrial inner 
membrane.  The iron atom at the center of the heme ring alternates between a reduced 
ferrous state and an oxidized ferric state during electron transport reactions.  Two of 
these mitochondrial protein complexes are cytochrome reductase complex (complex 
III) and cytochrome c oxidase (complex IV).  The cytochrome reductase complex 
contains three heme prosthetic groups, while complex IV, or cytochrome c oxidase, 
has two heme prosthetic groups (1).   
Hemoproteins are also involved in thyroid hormone synthesis (33). 
Thyroperoxidase is a membrane-bound hemoprotein that catalyzes the production of 
the thyroid hormones, thyroxine (T4) and 3,3’ 5-triiodothyronine (T3).  The trafficking 
of thyroperoxidase to the cell surface from the endoplasmic reticulum and subsequent 
enzymatic activity is dependent on insertion of heme into apo-thyroperoxidase.  
Heme must therefore be transported into the ER for incorporation into 
thyroperoxidase. Inhibition of heme biosynthesis significantly reduces 
thyroperoxidase trafficking to the cell surface and its subsequent enzymatic activity 





Heme as a regulator  
Heme also plays a regulatory role in many biological processes including cell 
growth, cell cycle progression, cellular differentiation, gene regulation, and 
microRNA processing.  This regulatory role can be cell-type specific.  While heme 
promotes cell growth and cell cycle progression in HeLa cancer cells, it promotes 
cellular differentiation in PC12 pro-neuronal cells and K562 erythroid cells (2).  
In HeLa cells, heme directly controls the cell cycle by acting on two key cell 
cycle regulators, cyclin-dependent kinases (CDKs) and p53 (34).  CDK proteins 
promote cell cycle progression, while p53 suppresses cell growth by activating cell 
cycle suppressor proteins and inducing BAX and Fas, two proapoptotic genes.  When 
DNA in a cell becomes damaged, the functional protein product of p53 induces the 
transcription of p31, whose protein product blocks the activity of CDK complexes.  
Inhibition of CDK complexes prevents the cell from progressing to the S-phase of the 
cell cycle, preventing damaged DNA from replicating.  When heme biosynthesis was 
inhibited in HeLa cells, they arrested in the S phase of the cell cycle and this cell 
cycle arrest was accompanied by morphological changes associated with senescence.  
Addition of heme reversed these effects.  Inhibiting heme synthesis increased p53 
levels four to five fold, an effect that was reversed when heme was added back to the 
medium, suggesting that heme has a direct effect on p53.  Conversely, inhibiting 
heme biosynthesis decreased the cellular levels of three CDK proteins: Cdk4, Cdc2, 
and cyclin D4.  Adding heme to these cells again reversed these effects (34). 





Heme is critical for neuronal differentiation via the Ras-ERK 1 and 2 signaling 
pathways (2).  Heme deficiency inactivates the Ras-ERK signaling pathways that are 
induced by nerve growth factor (NGF), a protein secreted by neurons that plays a 
crucial role in the differentiation of neural crest-derived sensory and sympathetic 
neurons.  Heme deficiency caused NGF-differentiated PC12 cells to undergo caspase 
activation and subsequent apoptosis.  Experiments also showed that undifferentiated 
PC12 cells were less vulnerable to heme deficiency.  This disparity in heme 
deficiency vulnerability between differentiated and undifferentiated cells suggested a 
role for heme in NGF signaling (2).  Additionally, male mouse embryos hemizygous 
for ALAS2 die at embryonic day 11.5 due to severe anemia.  The primitive erythroid 
cells did not mature, suggesting an additional role for heme in erythroid cellular 
differentiation (24).   
In addition to a direct role in controlling the cell cycle and cellular 
differentiation, heme also has an indirect role in regulating developmental timing 
processes, cellular differentiation, and apoptosis through its involvement in 
microRNA production (3).  MicroRNAs are short RNAs, generally twenty-two 
nucleotides long, that play a significant role in regulating protein-encoding genes.  
Ten to thirty percent of all protein-encoding genes are regulated by microRNAs.  
Recently, it was shown that heme plays a role in the activation of a protein critical to 
microRNA processing.  This protein, DiGeorge critical region-8 (DGCR8), requires 
heme for dimerization and subsequent activation.  After DGCR8 dimerizes, it binds to 
primary microRNAs, and the resulting trimer triggers cleavage of the primary 





regulatory role for heme could have severe ramifications for cells during heme 
deficiency.  In this case, heme deficiency would result in a reduction of mature 
microRNAs, an effect that could seriously impact multiple cellular processes. 
Recent work suggests that there is reciprocal regulation between heme 
biosynthesis and the circadian clock (6).   Circadian clocks play a crucial role in 
regulating physiology and behavior in organisms ranging from plants to animals (35).  
Research indicates that heme control of the circadian clock complex is 
transcriptionally regulated (6).  In Drosophila, the dperiod gene is an intrinsic part of 
the animal’s circadian clockwork.  Two dperiod homologs, mPER1 and mPER2 
regulate the mammalian circadian clock.  In mice, heme was shown to decrease 
expression of mPer2 but increase expression of mPer1, an effect most pronounced 
when the mice were subjected to complete darkness.  These results suggested 
involvement in the circadian clock.  Further studies showed that the expression 
patterns of mPer1 and mPer2 were differentially heme-regulated by NPAS2 and 
mPER2, two circadian clock proteins that bind heme.  When heme binds NPAS2, 
NPAS2 forms a transcription complex with BMAL1, a complex positively regulated 
by mPER2 in vivo.  This complex activates the ALAS1 promoter, thus inducing heme 
biosynthesis (6). 
In yeast, heme regulates gene expression through the heme-responsive 
transcriptional regulator, Hap1p (5).  In S. cerevisiae, Hap1p regulates the expression 
of ROX1, a gene that regulates expression of roughly one-third of all anaerobically 
expressed genes. Under aerobic conditions, ROX1 transcription is upregulated by 





oxygen levels determine heme synthesis in yeast, and, under long-term hypoxic 
conditions, oxygen-dependent heme synthesis decreases.  This is followed by a 
decrease in HAP1p activity and subsequent down-regulation of ROX1, which allows 
the expression of genes needed for hypoxic conditions (5).   
Hap1p is also involved in steroid biosynthesis in yeast in two ways.  One is by 
regulating HMG1, one of the genes in the sterol biosynthetic pathway, and the other 
is by playing a role regulating gene targets of the two transcription factors Upc2p and 
Ecm22p (36).  Upc2p and Ecm22p activate the ERG genes, which are responsible for 
sterol biosynthesis in yeast.  Under hypoxic conditions, Hap1p plays a role in 
regulating gene targets of Upc2p and Ecm22p, but precisely how it does this is not 
entirely clear.  Basal expression of another sterol biosynthetic gene, ERG2, requires 
Hap1p, regardless of whether the expression was activated by Ecm22p or Upc2p.  It 
is not clear whether sterols or heme are responsible for induction of these 
transcription factors under hypoxic conditions.  However, hypoxic induction of ERG 
genes responds to heme levels rather than sterol levels, a response that does not 
involve either Upc2p or Ecm22p (36).   
Heme degradation 
While heme biosynthesis is absolutely essential to cellular function, heme 
degradation is also an important aspect of cellular metabolism.  The main purpose of 
heme degradation is the reutilization of iron from hemoglobin (31).  Heme is 
degraded by heme oxygenase (HO) to ferrous iron, carbon monoxide and biliverdin. 





separate gene. HO-2 is the constitutive form of heme oxygenase, while HO-1 is 
highly inducible (2).   
HO-1 is regulated by Bach1, a heme-regulated mammalian transcriptional 
repressor (37). In human hepatocytes, silencing Bach1 upregulates HO-1 gene 
expression.  Bach1 downregulates HO-1 by forming heterodimers with Maf proteins 
and binding to the heme responsive elements (HeRes) in the 5’ untranslated region of 
the HO-1 promoter.  Heme binds to Bach1, causing a conformational change that 
markedly decreases the ability of Bach1 to bind HeRe elements.  When the Bach1 
complex no longer binds these binding sites on the promoter, the sites can then be 
bound by the HO-1 transcriptional activators, Maf-Maf and Nrf2-Maf (37). 
Heme transport  
Heme transport has been studied in a wide variety of organisms including 
bacteria, yeast, invertebrates, and mammals.  However, this field of research has been 
complicated because many model organisms are heme prototrophs, i.e. they 
synthesize heme.  Distinguishing between heme synthesized intracellularly and heme 
obtained from exogenous sources, therefore, is difficult without labeling one source 
of heme with fluorescent dyes, fluorescent molecules, or radioisotopes.  While 
prokaryotic heme biosynthesis is sufficient for prokaryotic heme demand (23), many 
bacteria obtain heme from exogenous sources to utilize as a source of iron (38).  
Many proteins directly responsible for heme uptake and transport in bacteria have 
been identified and characterized (38).   





proteins have been identified only recently.  Two genes with homologs in other 
pathogenic yeast species are required for heme uptake in the yeast Candida albicans 
(39).  In 2005, it was discovered that the model organism, C. elegans requires heme 
but does not synthesize it.  While C. elegans is non-pathogenic, there are pathogenic 
nematodes that also require heme but are unable to synthesize it (13).  These findings 
suggest that heme uptake could be an Achilles heel for some nematodes harmful to 
human, crop, and livestock health (13).  The pathways for how heme is transported 
into cells from external sources, transported between cells, and transported within 
cells, remains to be identified.  
Heme uptake has been well characterized in many bacterial species and the 
general mechanisms by which this occurs in gram-negative bacteria is demonstrated 
in Figure 2 (38).  Gram-positive bacteria contain specific binding proteins anchored 
to the inner membrane that recognize heme sources.  Once these heme sources are 
identified and bound, they are transported by ABC permeases.  
The first involves direct contact between heme or heme binding proteins and 
an outer-membrane receptor while the second system involves the release of proteins 
known as hemophores into the extracellular media by the bacteria.  The hemophores 
bind heme or heme-binding proteins such as hemoglobin and hemopexin, and deliver 
them to specific receptors located on the bacteria’s outer membrane.  The hemophore 
system has thus far been found only in gram-negative bacteria (40).  
 Two of these hemophore systems are the HxuA and HasA systems (38).  The 
HxuA system is found in Haemophilus influenza and is the only bacterial system 





Figure 2: Heme acquisition by gram-negative bacteria. 
Bacteria secrete hemolysin to degrade red blood cells (RBC’s), releasing hemoglobin 
and heme with heme being bound by albumin or hemopexin.  There are then three 
different ways in which the bacteria obtain the heme.   
1 Heme and hemoglobin can bind directly to a TonB-dependent outer 
membrane receptor.  
2 Bacteria release proteins called hemophores that capture hemoglobin and 
hemopexin.  The hemophores then bind to specific TonB dependent outer 
membrane receptors.  
3 Bacterial proteases, either membrane-bound or secreted, degrade 
hemoglobin, hemopexin, and albumin.  This process releases heme that  
subsequently binds to specific TonB –dependent receptors and is released 
into the periplasmic space.  Heme is then transported through the 
cytoplasmic membrane by a process that is not well described.  
 
Once heme reaches the cytoplasm it is degraded by heme oxygenase, releasing iron 
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heme, and contains the HxuABC gene cluster that allows it to efficiently utilize 
hemopexin, a heme-binding blood plasma protein.  HxuA is secreted, binds 
hemopexin and this complex binds to HxuA-hemopexin specific receptors.  The 
HasA system is found in at least five bacterial species and functions by capturing free 
heme or heme from hemoglobin and presenting it to specific outer-membrane 
receptors (40).  
Animals combat parasitic infections by limiting the amount of free iron in 
their blood.  Because of this limited availability of iron, many pathogenic 
microorganisms have evolved heme acquisition pathways that allow them to use 
heme from their host as a source of iron, and at least one species of pathogenic 
bacteria prefers heme iron over iron bound to transferrin (41).  Also, it has been 
shown that targeting heme uptake pathways of pathogenic bacteria can affect their 
virulency (41,42).  Mutating genes involved in the heme uptake system of the bacteria 
responsible for whooping cough in humans, Bordatella pertussis, reduced its infective 
strength in the mouse because the organism’s iron uptake systems were unable to 
compensate for the inability to acquire heme (42).  Mutating the heme uptake 
pathway in the gram-positive bacterium, Staphylococcus aureus, reduced its infective 
strength in the worm model, C. elegans (41). While proteins involved in bacterial 
heme uptake and utilization have been studied extensively, only recently have 
proteins with similar functions been discovered in eukaryotes.  Two recently 
discovered genes, RBT5 and RBT51, are responsible for heme uptake in C. albicans 
(9).  While these two proteins have a seventy percent identity to one another, RBT5 





confer to another yeast species, S. cerevisiae, the ability to utilize hemoglobin as an 
exogenous iron source (9). 
It was shown that Rbt5p and Rbt51p are heme receptors induced by iron 
starvation.  While these genes allow C. albicans to utilize heme as an iron source, the 
underlying molecular mechanism is not known.  One proposed mechanism is that 
these proteins facilitate the diffusion of heme through the plasma membrane.  
Another hypothesis is that Rbt5p could allow the heme to be taken up by a not-yet-
discovered heme transporter.  Alternatively, Rbt5/Rbt51 could be internalized from 
the plasma membrane with the heme where the heme is then released into the 
cytoplasm (9,43).  In addition to RBT5 and RBT51, C. albicans contains another gene 
essential to its ability to utilize hemoglobin as an iron source.  The gene, CaHMX1, is 
a heme oxygenase that is twenty-five percent homologous to human heme oxygenase.  
While CaHMX1 is the first gene known in C. albicans to be regulated by heme (44) 
and mammalian hemoglobin (45), its exact enzymatic activities are not yet clear.  
While C. albicans can become pathogenic and use heme as an iron source, mutating 
genes responsible for heme uptake did not reduce its virulency in the mouse model.  
Two additional pathogenic yeast species, however, efficiently utilized heme as an 
iron source and the proteins responsible for this are homologous to Rbt51p, indicating 
a possible vulnerability of these pathogens to heme deficiency (9).  
Worldwide, pathogenic nematodes cause significant problems for humans, 
crops, and livestock.  One-third of Earth’s human population is infected with soil-
transmitted helminths and the majority of those infected live in the developing world 





combat these helminthic infections in humans, increasing the likelihood of drug 
resistance.  Although anthelmintic drug resistance in humans has not yet become a 
problem, wide-spread use of anti-helminths in the animal husbandry industry has led 
to rampant drug resistance (47).  Recent studies suggest that a potential Achilles heel 
and novel pharmaceutical target for some of these parasites is heme uptake (13).  
When it was discovered that the non-parasitic model organism C. elegans is a natural 
heme auxotroph, further studies revealed that five other phylogenetically diverse 
species of parasitic nematodes also depend on heme acquisition from exogenous 
sources (13).   
Another recently published report suggests that host dietary iron supply 
affects the ability of the hookworm Ancylostoma ceylanicum to infect its host (48).  
Hamsters infected with A. ceylanicum and fed a diet with severe iron restriction, had a 
significant reduction in the parasite load compared to animals that were fed a diet 
with moderate levels of iron.  These results suggest that hookworms rely on the host 
iron to maintain growth and development.  Host iron deficiency may lead to impaired 
host heme production, affecting the ability of hookworms to sustain infection.  This 
discovery has potential ramifications for how humans are treated for hookworm 
infection.  Traditionally, patients infected with hookworms are at risk for becoming 
anemic and are given iron supplements as part of their treatment.  Results from this 
study, however, suggest that this treatment could actually be allowing the parasite to 
thrive in its host (48).    
Correspondingly, another nematode that may lack heme biosynthetic enzymes 





worldwide (49).  Genomic studies of two other filarial nematodes suggest the 
possibility that Brugia malayi requires heme for reproduction and development via 
hemoproteins that catalyze hormone biosynthesis.  It appears that B. malayi may be 
another natural heme auxotroph and it likely obtains heme either from its host or 
possibly from Wolbachia, an endosymbiotic bacterium.  Wolbachia contains all but 
one of the heme biosynthetic enzymes and is most likely responsible for supplying 
heme to B. malayi.  In human trial studies, B. malayi infected patients have been 
successfully treated using antibiotics that target Wolbachia.  Targeting the heme 
uptake pathway in Brugia malayi is another potential pharmaceutical target as it 
appears that the survival and growth of this organism requires heme (49).   
 The field of mammalian heme transport has only recently begun to identify 
genes involved in this process.  Two mammalian mitochondrial porphyrin 
transporters have been identified, one of which also appears to transport heme 
(10,12).  Additional advances in mammalian heme transport have revealed two genes 
responsible for heme export in hematopoietic stem cells (11,50).  One of the 
mammalian mitochondrial porphyrin transporters discovered is ATP-binding cassette 
transporter ABCB6, which locates to the outer mitochondrial membrane and is 
required for mitochondrial porphyrin uptake (12).  Experiments conducted in two 
mouse models demonstrated that the expression of this protein directly responded to 
intracellular amounts of heme.  Mice treated to enhance splenic erythropoiesis 
showed an increase in Abcb6 mRNA.  Abcg2, also known as the breast cancer 
resistance gene  (Bcrp1), is a member of the ATP-binding cassette family of drug 





that have higher levels of protoporphyrin IX, mRNA levels of Abcb6 were 
significantly higher in the bone marrow, liver, kidney, and testis (12).  Heme 
biosynthesis, erythroid differentiation, and intracellular levels of protoporphyrins 
were shown to directly influence levels of murine ABCB6 in vivo.  In K562, SAOS-2, 
and MEL cells, overexpression of Abcb6 had a six to thirteen fold increase in 
accumulation of protoporphryn IX, an increase blocked by the heme synthesis 
inhibitor, succinyl acetone, suggesting that increasing Abcb6 expression increased 
heme biosynthesis.  ABCB6 associates with the outer mitochondrial membrane and is 
thought to transfer coproporphyrinogen III to the enzyme coproporphyrinogen 
oxidase which resides on the inner mitochondrial membrane to facilitate heme 
biosynthesis (12).   
Another mitochondrial porphyrin transporter recently characterized is 2-
oxoglutarate carrier (OGC), an inner mitochondrial membrane protein known to 
facilitate uptake of 2-oxoglutarate into the mitochondria (10).  The studies involved 
the use of two fluorescent porphyrin derivatives PdTCPP and PdTAPP.  PdTCPP 
accumulated in the mitochondria and co-localized with the mitochondrial marker, 
Mito Tracker.  OGC was identified as the protein bound to PdTCPP by using latex 
bead technique and mass spectrometry.  It was then shown that 2-oxoglutarate uptake 
into the mitochondria was inhibited by porphyrin derivatives.  Uptake of PdTCPP 
into the mitochondria was prevented by 2-oxoglutarate, while hemin and two heme 
precursors, protoporphyrin IX and coproporphyrin III, inhibited 2-oxoglutarate uptake 
into the mitochondria.  This carrier protein is conserved in yeast and humans and may 





(10).  In spite of these promising results, there are a few caveats in this study.  One is 
the primary role of the synthetic fluorescent derivative PdTCPP, a compound whose 
physiological properties are not clear.  Another question to address is why heme 
would be transported into the mitochondria.  And finally, in each of these papers 
(10,12), the authors used the commercially available oxidized planar conjugated 
macrocycle, coproporphyrin III, rather than the physiologically relevant substrate 
coproporphyrinogen III, a reduced nonplanar porphyrin (52).   
Until recently, no proteins that specifically transported heme had been 
identified. Within the last two years, two mammalian heme transporters were 
identified: the feline leukemia virus receptor (FLCVR) and the ABC transporter 
(ABCG2) (11,50).  Both of these apical membrane proteins were shown to facilitate 
the export of heme from hematopoietic stem cells, preventing toxic levels of heme 
from accumulating.  Preventing expression of FLVCR by siRNA causes a decrease in 
the number of colony-forming unit erythrocyte cells, induces apoptosis, and 
subsequently prevents erythroid differentiation.  Expression of FLVCR in CaCO-2 
cells reduces cellular heme concentration during intestinal cell differentiation (31).  
While the role of FLVCR in intestinal and liver tissues remains unclear, ABCG2 
localizes on the apical membrane of duodenal enterocytes and in other regions of the 
gastrointestinal tract.  The definitive function of these proteins as heme exporters in 
the intestine remains to be explored.  
Currently, the protein or proteins responsible for dietary heme absorption into 
intestinal cells are unknown.  While it was recently reported that the long-sought 





several months later reported that HCP1 is a proton–coupled folate transporter and 
that it could not be more than a poor heme transporter (53).  Therefore, the search for 
a mammalian gene or genes that facilitate intestinal heme uptake continues.  
Techniques used to localize heme  
There have been many techniques developed to localize heme within cells, 
many of which involve fluorescent (14,15), histochemical (7,8), and radiolabeling  
approaches (16).  Recently, heme trafficking was observed in live cells for the first 
time in the cattle tick, Boophilus microplus (15).  This parasitic heme auxotroph relies 
on the blood of its host for nutrients and can ingest quantities of blood up to one 
hundred times its own body mass.  During the ensuing breakdown of hemoglobin, 
potentially toxic levels of heme are generated and sequestered into a recently 
described organelle called the hemosome (54).  To observe heme trafficking within 
the cell, researchers used the fluorescent heme analog Palladium–mesoporphyrin IX 
(Pd-mP) (15).  Pd-mP fluoresces red when bound to proteins and green when free.  
This enabled the researchers to determine when and where the heme analog was 
bound to proteins in live digest cells of the B. microplus.  Pulse-chase experiments 
revealed the heme analog was bound to protein while being trafficked from digestive 
vesicles through the cytoplasm, and then transported into the hemosome.  When the 
analog was present in the cytoplasm, it fluoresced red and this fluorescence 
intensified at the edge of the hemosome (15).  
Histochemical staining methods have also previously been established to 





3’diaminobenzidine (DAB) (7).  This technique exploits the oxidative property of the 
ferrous iron (FeII) within the tetrapyrrole ring.  The iron in the center of heme reacts 
with hydrogen peroxide to generate hydroxyl radicals as shown in the following 
equations: 
 
Fe2+ + H2O2 --> Fe3+ + .OH + OH- 
Fe3+ + H2O2 --> Fe2+ + .OOH + H+ 
 
Hydrogen peroxide oxidizes FeII of heme to ferric iron (FeIII), a hydroxyl radical, 
and a hydroxyl anion.  FeIII is then reduced back to iron II by another round of 
reaction with hydrogen peroxide to a FeII peroxide radical, and a proton.  The 
hydroxyl radicals oxidize DAB, producing a localized red-brown product.   
This technique has been used to study heme absorption in the rat (7) and dog 
(8) models.  Rats, like many eukaryotes, synthesize heme in addition to taking it up 
from their diet.  The purpose of this study was to follow the pathway of intestinal 
heme uptake in the rat duodenum.  Electron micrographs showed that heme was 
released from hemoglobin in the intestinal lumen, then entered the mucosal cells 
through the apical pits.  The heme was next observed in the apical tubules, and was 
finally observed in the secondary lysosomes of the apical and supranuclear regions of 
the cell (7).  However, the experimental conditions differed greatly from normal 
heme uptake by the rat.  The heme was administered surgically to the animals in 
quantities sufficiently large enough see a reaction product generated by DAB (7).  





hemoglobin–iron absorption through intestinal epithelial cells is different from the 
absorption of inorganic iron (8).  Studies using this model concluded that endocytosis 
appeared to play a major role in heme absorption, offering insight into a possible 
route of hemoglobin-iron. 
  In the current study, we have established a whole animal heme staining 
methodology using the natural heme auxotroph, C. elegans.  By carefully controlling 
the heme levels in the growth medium of this nematode, we characterized heme 
localization in mutants which show aberrant growth in response to heme and in wild 
type N2 worms.  To our knowledge, this is the first time heme localization has been 
characterized in a whole animal.  This established protocol will enable us to further 
our current understanding of eukaryotic heme trafficking by providing a conceptual 





Chapter 2: Materials and Methods 
 
Worm strains and growth medium 
The N2 wild-type strain of C. elegans was used for all experiments except where 
indicated.  Mutant worm strains IQ911, IQ1068, IQ938, IQ731, IQ828 were obtained 
by Dr. Anita Rao.  These mutants are capable of surviving in high levels of heme (> 
800 µM) that are otherwise toxic to wild-type worms.  The worms were grown in 
axenic CeHR medium that was modified (mCeHR) to eliminate all sources of 
exogenously added heme under aerobic conditions at 20°C in tissue culture flasks.  
Synchronized L1 larvae were added to mCeHR axenic liquid medium at a population 
level of ~1500 worms/mL and grown in designated heme concentrations until they 
reached the mid-L4 larval stage, at which point they were fixed, permeabilized, and 
stained for heme.  
Worm permeabilization and fixation for light microscopy 
N2 worms were grown to the gravid stage in growth medium containing 20 
µM hemin chloride (Frontier Scientific, Logan, UT) and bleached [1.1 % Clorox 
bleach (sodium hypochlorite)/0.55 M NaOH] to harvest the eggs.  Eggs were washed 
2-3 times with M9 buffer (86 mM NaCl (Fisher, #S271-43), 42mM Na2HPO4 (Fisher, 
#S774), 22mM KH2PO4 (Acros, #42420-5000), 1mM MgSO4 7H2O (Acros, 
#423905000)) and synchronized by hatching overnight in M9 buffer solution.   
When the worms reached the L4 larval stage, they were harvested for fixation 





solution and then incubated in the M9 buffer solution for 1 to 3 h to empty gut 
contents.  Afterwards, the animals were transferred to a 1.5 mL microfuge tube, 
allowed to settle for 10 min, washed with 1.0 mL distilled water and allowed to settle 
for an additional 10 min.   
The permeabilization method was modified from a previously published 
method (55).  After the supernatant of the settled worms was aspirated, the microfuge 
tube was placed on ice.  One ml of ice-cold paraformaldehyde solution [50 % 
Modified Ruvkin’s Witches Brew: (160 mM Potassium Chloride (Acros, #42409-
0010), 40 mM NaCl (Fisher Scientific, #S271-3), 20 mM EGTA-Sodium salt, 10 mM 
spermidine HCl (MP Biomedicals, #194542), 30 mM Pipes pH 7.4 (Acros, 17261-
1000), 50 % methanol (Fisher, #A412-4), 40 % distilled water, 2 % paraformaldehyde 
(Sigma, #41678-0010)] was added to the centrifuge tube containing the worms and 
the contents were mixed gently so to avoid damaging the worm tissues.  The 
centrifuge tube was incubated at 4°C for 35 min with occasional mixing.  Following 
this step, the worms were allowed to settle and washed twice with 1.0 mL Tris Triton 
Buffer [100 mM Tris HCl pH7.4 (Acros, #14050-0025), 1.0 % Triton X-100 (Acros, 
#422435-5000), and 1.0 mM EDTA (Acros, # 40997-5000)].  The animals were then 
incubated at room temperature in 1.0 mL of 1 % β-mercaptoethanol (Acros, #12547-
1000) in TTB for 15 min at eight RPM on a platform shaker (Platform shaker by 
Barnstead Thermolyne).  The worms were washed once with 1X borate buffer 
[25mM H3BO3, 12.5mM NaOH)] and allowed to settle.  One mL of 10 mM DL-1,4 
Dithiothreitol 99 % (Acros, #16568-0050) in 0.9X borate buffer (22.5 mM H3BO3, 





on the Labquake shaker for 15 min at room temperature.  The worms were then rinsed 
five times with distilled water and stored overnight at 4°C in PBS buffer [13.7 mM 
NaCl (Fisher # 5271-3), 0.27 mM KCl (Acros, #42409-0010), 0.43 mM Na2 HPO4 
(Acros, # 42437-5000), 0.14 mM KH2PO4 (Acros, # 42420-5000) that had been 
deoxygenated with N2 gas.   These fixed and permeabilized worms were stained the 
following day.  
Pre-staining solution to eliminate oxygen radicals 
To eliminate oxygen radicals that can oxidize the staining chemical, 97 % 3-
3’diaminobenzidine tetrahydrochloride, 97 % (Acros, #112090050) solutions used in 
all experiments (unless otherwise noted) were deoxygenated by flushing with 
nitrogen gas for 15 - 20 min just prior to staining.  Fixed and permeabilized worms 
were rinsed three times with deoxygenated potassium phosphate buffer (pH 7.4)  
(4.05 mM K2HPO4 and 0.95 mM KH2PO4) incubated in the dark at 37°C for 2 hr in a 
solution containing 0.2 % bovine liver catalase (Sigma, # C-1345) (56),  0.04 % 
bovine liver superoxide dismutase from bovine liver (Sigma, #S-186) in  potassium 
phosphate buffer, pH 7.4.  The worms were then rinsed twice with deoxygenated 0.06 
M Tris HCl buffer (pH 8.0-8.2). 
Heme staining for light microscopy 
A solution of 0.15 % DAB in 0.06 M Tris HCl (pH 8.0-8.2) was added to all samples. 
Then, H2O2  (Sigma, #H1009) was added to each staining group for a final 





of H2O2.  All samples were incubated for 30 min under deoxygenated conditions and 
rinsed three times with deoxygenated, distilled H2O.  The worms were mounted on 
0.1 %– 0.2 % agar (Fisher Bioreagents, # BP26411) beds, prepared on glass slides 
and photographed using a Leica DMIRE2 DIC microscope fitted with a Retiga 1300 
cooled 12-bit CCD camera and imaged with SIMPLEPCI version 5.2 Software 
(Compix, Inc.).  
Heme staining analysis 
The control groups of worms were always evaluated before the experimental groups 
to ensure that staining in the controls was sufficiently minimal to permit analysis.  
Staining in the controls typically varied slightly in intensity, but the final reported 
percentage of staining in the controls included all variations of staining intensity.  The 
majority of control groups in the following experiments had ~ 10 % staining.  One or 
two slides containing worms from the control group was evaluated.  Each slide 
contained ~300-500 worms.  The entire slide was examined to determine the percent 
of worms stained out of the whole group.  The experimental groups were evaluated in 
the same manner as the control group.  While there was some variation in staining 
intensities in the experimental samples, final conclusions were based upon the degree 
to which > 70 % of the worms stained.  
Worms were examined and photographed using bright field light microscopy.  
Differential interference contrast (DIC) microscopy was not used in the majority of 
the heme staining experiments due to difficulties capturing heme staining in 






An unsynchronized population of wild-type worms were grown at 20 µM heme and 
fixed by the chemical fixation method described in this section.  The worms were 
then stained with a 1 µg/ml DAPI solution (Sigma, #32670) for 10 min at room 
temperature.  
Worm fixation and permeabilization using microwave fixation 
Due to poor preservation of tissue structure integrity, the fixation and 
permeabilization method used for light microscopy could not be used for electron 
microscopy.  Instead, a C. elegans fixation and permeabilization protocol was 
modified from a previously described method (57) (communication,  Dr. David Hall 
at the Albert Einstein College of Medicine).   Wild–type N2 worms were grown in 
axenic mCeHR medium containing 80 µM heme.  When the worms reached mid-L4 
stage, they were rinsed once with M9 buffer solution and incubated in the M9 buffer 
solution for 1 to 3 h to clear gut contents.  The M9 buffer solution was changed once 
every hour.  Worms were washed once with distilled H2O and placed on ice for 
transport to the University of Maryland Laboratory of Biological Ultrastructure  
(LBU) for microwave fixation (Pelco 3440 Laboratory Microwave oven and Pelco 
3420 Microwave Load Cooler).  At the LBU, the worms were rinsed three times with 
fixative solution [1.0 % glutaraldehyde (Acros, # 233280250), 0.05 M sucrose 
(Acros, #220900010), and 0.1 M Hepes, pH 7.4. (Sigma, #H-3375)] and placed into 
one well of a three-well glass chamber slide.  The hotspots of the microwave were 





the hotspots.  The hotspots were predetermined using a probe placed over the grid 
located on the floor of the microwave oven.  The probe contained individual bulbs 
that aligned with each grid box. When the microwave was turned on, the bulbs that 
flashed red indicated the areas of the grid that contained the hotspots.  These hotspots 
varied from use to use.  The glass chamber slide was placed into an ice bath (a 150 
mm Petri dish full of crushed ice).  The chamber well containing the worms was 
placed directly over a previously determined hotspot.  The worms were microwaved 
at 70°C at full power for 1.5 min ON and for 2 min OFF for a total of five cycles.  
After each cycle, the glutaraldehyde fixative solution and the ice bath were changed.  
This process was repeated five times. Once these five cycles were completed, the 
worms were microwaved at the same temperature and power settings for 1 min for 
three cycles with a 4 min recovery period.  The total time exposed to microwave 
energy was 10.5 min.  The animals were then incubated at 37°C for 1 h in the 0.2 % 
catalase and 0.04 % superoxide dismutase solution in 5 mM phosphate buffer, pH 
7.4., described earlier.  The worms were rinsed twice with 0.06 M Tris HCl (pH 8.0-
8.2) and divided into control and staining groups.  
Heme staining for electron microscopy 
A solution of 0.15 % 3-3’diaminobenzidene, 0.06 M Tris HCl (pH 8.0-8.2), and 0.06 
% H2O2 was used to stain worms for 30 min at room temperature under deoxygenated 
conditions.  The control group was incubated in the absence of hydrogen peroxide.  
After staining, the worms were rinsed three times with deoxygenated, distilled water.  





osmium tetroxide (EMS, 19140) for 33 min at room temperature.  The worms were 
then washed five times with deoxygenated, distilled water and embedded in epoxy 
resin.  
Worm embedding  
All materials used for embedding were purchased from Electron Microscopy Services 
(EMS, Fort Washington, PA) unless otherwise noted.  Agarose beds were made by 
pouring 3.0 - 4.0 mL of 3.0 % Low Melt Preparative Grade Agarose (BioRad, 162-
0019) into 60 mm petri dishes.  Approximately four to twelve worms were arranged 
side by side on top of the first layer of the solidified agarose and then covered with 
another 3.0 to 4.0 mL of agarose, so the worms were sandwiched between the two 
beds.  The Petri dishes were stored overnight at 4.0°C with a few drops of water on 
top of the agar beds, to prevent the agar from drying out.   
  The next morning, each group of worms were cut out of the bed with a razor 
blade to a size that would fit into the tips of the embedding molds (Pelco 
International, #105).  Each piece of agarose contained four to twelve worms that 
could be placed coronally or sagitally into the tips of the mold.  The pieces of the 
agarose beds could not be bigger than the mold nor smaller than the tip of a Pasteur 
pipette.  The worm samples in agarose were dehydrated by placing them in 25 mL 
glass bottles and incubating for 5 min in each of the following ethanol grades: 30 %, 
50 %, 75 %, and 95 %.  For the final ethanol dehydration step, the worms were 
incubated in 100 % ethanol three times, each time for 10 min.  Further dehydration 





Epoxypropane, Methyloxirane,  (#20412).  All PO steps were conducted using only 
glass or polypropylene equipment, as PO is highly reactive.  The agarose pieces were 
incubated in PO three times, each time for 10 min.  Worms were incubated in a 2:1 
ratio of PO:resin mixture for 2 to 3 h on a vertical rotator (Barnstead Thermolyne) at 
room temperature.  The resin mixture contained 45.0 % Embed 812 (#14900), 30.0 % 
Dodecenyl Succinic Anhydride (DDSA) (#13710), 25.0 % Nadic Methyl Anhydride 
(Methyl-5-Norbornene-2,3-Dicarboxylic Anhydride) (#19000), 1.5 % DMP-30 
(2,4,6-Tri (dimethylaminomethyl) phenol, (#13600).  Resin was made fresh for each 
experiment and stored under vacuum in a room temperature desiccator.  The worm 
sections were then incubated in a 1:2 PO:resin solution overnight at room temperature 
on the vertical rotator.  Approximately 15 h later, the agarose pieces were removed 
from the PO: resin mixture and placed into resin for 3 h at room temperature.  During 
this 3 h incubation period, the resin was changed twice.  Following the second change 
of resin, the agarose pieces were positioned at the tip of the embedding mold with the 
worms either coronally or sagitally placed.  Small pieces of paper with the assigned 
sample code, which differentiated the samples from one another, were placed into the 
molds.  Resin was poured into the embedding molds, making sure the worms 
remained correctly aligned at the tip.  The molds were cured for 3 days at 60°C, 
removed from the oven, and allowed to cool for at least half a day.  
Thin sectioning  
At the end of the embedding process the worms were thin-sectioned for electron 





(Ultramicrotomy grade glass (# 71012) generated by a glass knife cutter (LKB 7800B 
Knifemaker).  Water boats to catch the thin sections, were made with plastic water 
boats (#71007) and sealed to the glass knife with clear nail polish (#72180).  A 
chloroform solution was used to flatten the sections and a Zerostat Ion Gun (153) was 
used to minimize static electricity.  The sections were approximately 60 nm – 90 nm 
thick, and were placed on coated 375–mesh copper grids.  The samples on the grids 
were counterstained with lead citrate (#17800) and uranyl acetate (#22400).  The 
uranyl acetate solution was made by dissolving 0.2 g dry uranyl acetate in 10 mL of 
distilled H2O.  This solution was stirred overnight at room temperature.  The lead 
citrate solution was made by dissolving 0.03 g in 10 mL H2O and adding 0.1 mL 10 
M NaOH, shaking vigorously by hand for 5 min and storing overnight at 4°C.  Prior 
to staining, these solutions were centrifuged for 10 min at room temperature to 
remove any particulate matter.  Electron micrographs were taken under the direction 






Chapter 3 Characterization of heme localization in wild-
type worms using light microscopy 
 
Summary 
Heme is a tetrapyrrole essential to life for many organisms.  In most of these 
organisms, heme is both synthesized in a well-conserved eight-step pathway, as well 
as absorbed from the diet.  Heme uptake has been studied morphologically since the 
1960’s, but most of the animals used for those studies were heme synthesis 
prototrophs.  We use the nematode Caenorhabditis elegans as the model organism of 
choice to study heme transport because we recently discovered that it does not 
synthesize heme but utilizes heme from diet (13).  Thus, the in situ study of heme 
uptake in this animal will provide a better understanding of how heme transport is 
mediated in eukaryotes without interference from endogenous heme sources.  Here, 
we show that, by using a DAB staining technique and light microscopy, C. elegans 
stains robustly for heme, revealing a direct correlation between histochemical heme 
staining and the level of nutritious heme administered exogenously in the growth 
media.  Wild-type worms that were grown at 1.5 µM, 4.0 µM, 20 µM, 40 µM, and 
100 µM heme showed a proportional increase in the intensity of heme staining.  Our 
systematic standardization of the methodology of heme staining builds upon earlier 
work, and establishes an in vivo approach to directly visualize heme in an intact 
whole animal.  This new method is a useful starting point for the study of in situ heme 






This research project was designed to cytologically localize and characterize heme 
staining in C. elegans using microscopy.  The overall research goal of our research 
group is to discover the molecules controlling heme transport pathways in C. elegans.  
C. elegans is a free-living nematode that does not synthesize heme, but requires 
exogenous heme for incorporation into hemoproteins (13).  We hypothesize that 
specific intracellular pathways must exist for heme transport because heme is an 
essential molecule that cannot simply diffuse into, within and between cells due to its 
hydrophobicity and cytotoxicity.  C. elegans is an ideal organism to address questions 
pertaining to heme transport for a number of reasons.  First, C. elegans does not 
contain any of the well-conserved genes required for heme biosynthesis,  and thus we 
have complete control over heme transport in the animal.  Second, C elegans is 
translucent, proving to be an ideal system to localize heme within cells and organs in 
the intact animal.  Third, C. elegans is a well-established genetic model with invariant 
somatic cell number.  It has been used for genetic and cell biological studies for more 
than thirty-five years (58). 
Complete control of heme transport is difficult to attain in eukaryotic 
organisms that synthesize heme (13).  Establishing a protocol for in situ heme 
labeling using the chromogenic substrate 3-3’ diaminobenzidine (DAB) will allow us 
to gain a better understanding of where hemes are localized and transported in vivo in 
C. elegans, a natural heme auxotroph.  Histochemical staining with DAB exploits the 





study heme uptake and trafficking in various model organisms.  When hydrogen 
peroxide is added as a second substrate, the iron in the center of the heme ring reacts 
with the hydrogen peroxide, releasing oxygen radicals.  These oxygen radicals 
oxidize DAB and produce a localized brown/red reaction product (17).  Previous 
heme labeling microscopy studies in other organisms used artificially elevated heme 
levels in organ slices.  The studies described herein, however, localize histochemical 
heme in situ in intact C. elegans under normal and varying levels of physiological 
heme concentrations.   
Results 
Our goal for this project was to cytologically localize heme in whole animals using C. 
elegans.  This manner of cytologically localizing heme in worms has not been 
reported in the literature.  As a starting point, we conducted our first staining 
experiment by attempting to use a procedure established by Graham and Karnovsky 
(17).  This study described a new histochemical staining technique using DAB, to 
study horseradish peroxidase absorption in the mammalian kidney, using the rat 
model.  This method involved incubating the worms for 10 min in a DAB-saturated 
staining solution in 0.05M Tris HCl buffer, pH 7.6.  Two groups of worms were 
tested with this staining procedure.  The first group of worms had been fixed and 
permeabilized two days earlier as described in the Materials and Methods section 
(59).  The second group of worms was fixed and permeabilized by the same method, 
on the same day.  Within 10 min of the staining reaction, the worms in the control 





However, no staining appeared in either the control group (minus H2O2) or the 
experimental group (plus H2O2) of the worms that had been fixed on the same day.  
After these results, we decided to try to modify the protocol as described by 
Simionescu et al., that was used for one of the first EM studies for heme uptake in 
mammalian intestine (60).  This modification called for a staining incubation period 
of 60 min and for the DAB Tris-HCl buffer solution to have a pH of 8.0.  This 
experiment produced significant levels of non-specific staining.  We then decided to 
try to establish our own heme staining methodology.  
Addition of catalase to pre-incubation solution 
 
Our first heme staining experiment, based on a previously published method (17) 
produced inconclusive results.  There was no difference in staining between the 
worms in the control samples and worms in the experimental samples.  Our first 
thought was that endogenous hydrogen peroxide could be oxidizing DAB, producing 
non-specific staining in the control samples.  To eliminate this endogenous hydrogen 
peroxide, we incubated the worms, post-fixation, in a 0.2 % catalase (CAT) solution 
in 5 mM phosphate buffer for 30 min at 37°C, as described in the Materials and 
Methods section.  CAT is the enzymatic catalyst in the chemical reaction below: 
CAT 
2 H2O2 --->2 H2O + O2 
 
 
While there was still significant non-specific staining, we noticed for the first time 
that gravid worms contained the majority of the non-specific staining.  Staining was 





Figure 3: Addition of CAT to eradicate peroxide radicals. 
A mixed population of N2 worms grown at 20 µM heme in mCeHR medium was 
permeabilized as described in Materials and Methods and stored overnight in PBS at 
4°C.  After 15 h, the worms were incubated in 5 mM potassium phosphate buffer, pH 
7.4 containing 0.2 % CAT for 30 min at 37°C, in the dark.  The staining reaction was 
carried out for 30 min at room temperature.  Staining in the control samples incubated 
with CAT by ~ 40 %.  This experiment was performed one time, and each 









While we achieved a significant improvement in the non-specific staining of 
the controls by adding the CAT step, we felt it was necessary to further standardize 
the staining procedure.  We tested three additional concentrations of CAT for a longer 
period of time to see if there would be any differences in the staining of our control 
samples.  In addition to the 0.2 % used originally, we tried 0.02 %, 0.1 %, 0.2 % and 
1.0 % of CAT in 5mM phosphate buffer, pH 7.4 for 2 h at 37°C.  No differences were 
detected in staining of the controls between these four concentrations.  The 
experimental samples of gravid worms in each of the different concentrations of CAT 
stained only 30 - 40 % greater than the gravid worms in the control samples.  We 
again noted that the gravid worms in the control samples had non-specific staining 
while the non-gravid adults and larval worms in the control samples had very little, if 
any, non-specific staining.  Experiments conducted later confirmed that larval worms 
consistently had less non-specific staining than gravid worms. 
Addition of SOD to pre-incubation solution.  
Although we significantly reduced the non-specific staining in our control samples by 
incubating the worms with CAT, we added another modification.  Since endogenous 
H2O2 is generated by the reaction catalyzed by the enzyme superoxide dismutase 
(SOD), we rationalized that pre-incubation with SOD would help reduce the non-
specific staining observed in the control samples.  SOD catalyzes the following 


































Surprisingly, > 90 % of the worms in the experimental group stained for heme, while 
< 5 % of the control group revealed non-specific staining.  The staining observed in 
the experimental group was throughout the entire worm and the staining intensity was 
uniform, as shown in Figure 4.  No other distinct staining patterns were observed.  
Heme staining unsynchronized worms grown at 20 µM and 100 µM heme 
The addition of SOD and CAT to our protocol showed promising results by reducing 
the non-specific staining.  We then decided to try and compare staining levels 
between two mixed, unsynchronized populations of worms grown at 100 µM and 20 
µM heme.  The worms were fixed, permeabilized, and 15 h later, pre-incubated with 
0.2 % SOD and 0.2 % CAT in 5 mM phosphate buffer, pH 7.4.  The worms were then 
stained for heme with 0.15 % DAB in 0.06 M Tris HCl, pH 8.0.  The results from this 
experiment are shown in Table 1.  During this experiment there were no differences 
in staining between the gravid worms, and their embryos, in the control and 
experimental groups.  DAPI staining of the nucleus in these worms, described in 
Materials and Methods, revealed that >75 % of the eggs and 90 % of worms were 
permeabilized.  Control samples of worms grown at 20 µM and 100 µM heme did not 
differ in their staining intensity.  Importantly, worms grown at 100 µM heme from the 
experimental group had significantly darker and more intense heme staining than 
experimental worms grown at 20 µM heme.  This experiment indicated that worms 
grown in different concentrations of heme display differences in the intensity of heme 
staining.  These results also indicated that gravid worms have significantly higher 





Figure 4: Addition of SOD to erradicate oxygen radicals. 
A mixed population of wild-type worms was grown in 20 µM hemin and their F1 
progeny were synchronized as described in Materials and Methods.  The L1 larvae 
were inoculated into 20 µM heme in mCeHR medium.  At the L4 larval stage the 
worms were harvested, fixed, permeabilized, and stored overnight at room 
temperature.  The following morning the worms were incubated in a pre-incubation 
solution of 0.2 % CAT and 0.2 % SOD in 5 mM phosphate buffer for 1 h.  The 
worms were subsequently stained for heme.  Less than 5.0 % of the control samples 
stained while > 90 % of the experimental samples stained.  This experiment was 









Table 1: Larval worms have significantly less non-specific staining than gravid 
worms.  
The majority of worms in the control group that stained were gravid.  Approximately 
5 % of the larvae in the control samples had non-specific staining. Greater than 85 % 
of the stained worms in the experimental group, however, stained specifically for 
heme.   
 
[Heme] Control Experimental 
 Gravids Larvae Gravids Larvae 
20µM ~40 % 5 % > 90 % > 85  % 






To eliminate the problem of non-specific staining in gravid worms, we conducted our 
next experiment using only larvae.  This experiment was also designed to further test 
the possibility of differential heme staining of worms grown at different heme 
concentrations.   
Heme staining in synchronized L4 larvae at 20 µM and 100 µM heme  
To test whether worms that were grown in higher heme concentrations stained more 
intensely than worms grown at lower heme levels, synchronized L1 larvae were 
grown in mCeHR medium in 20 µM and 100 µM heme.  The results are shown in 
Table 2 and Figure 5.  Worms grown in 100 µΜ heme stained approximately 2- 3 
fold more intensely than worms grown in 20 µΜ heme as shown in Figure 5.  
Synchronized L4 larvae grown at 1.5 µM, 4 µM, 20 µM, and 40 µM heme were 
stained for heme using deoxygenated conditions. 
 
While we significantly improved the specific staining with the addition of SOD and 
CAT, and using only larval worms, we observed that worms in the control group 
would begin to stain during the rinsing process, post staining.  Because staining 
results from the oxidation of DAB, it was possible that oxygenation of the rinsing 
solution was causing this experimental artifact.  We decided to go one step further 
and stain the worms, now under deoxygenated conditions, using the apparatus shown  
in Figure 6.  The results are shown in Table 3 and Figure 7.  As might have been 
predicted, worms grown in 40 µM heme stained the most intensely. The worms 
grown in 20 µM heme concentrations stained slightly more intensely than the L4 





Table 2: Synchronized L4 larvae exhibit specific heme staining. 
Approximately 5 % of the 100 µM larvae revealed staining throughout the body in 
the control group.  Worms grown at 100 µΜ heme showed  > 95 % heme staining in 
the experimental group and > 80 % of those worms showed uniform staining 
throughout the body.  Worms grown at 20 µΜ  showed staining in > 80 % of the 
experimental group and this staining was throughout their body.  Less than 5 % of the 
20 µM worms stained in the control group. 
 
[Heme] Control  Experimental  
20 µM < 5 % > 95 % 






Figure 5: Synchronized L4 larvae grown at 20 µM and 100 µM heme exhibit 
differences in heme staining intensity. 
Synchronized L1 larvae obtained from N2 worms grown in 20 µM heme were 
inoculated into mCeHR medium containing either 20 µM or 100 µM heme.  When 
these larvae reached the L4 stage, the worms were fixed, permeabilized, and stored 
overnight as described in Materials and Methods.  Approximately 15 h later, the 
worms were stained for heme.  The experimental samples from the worms grown at 
100 µM heme stained 2 -3 fold more intensely than the worms grown at 20 µM heme.  
This experiment was performed one time and each micrograph is a representative 









Figure 6: Experimental apparatus for deoxygenation of worm samples. 
Each of the worm samples were contained in a plastic test tube fitted with a rubber 
septum.  The needle of the apparatus was the source of N2 gas for the test tubes 
containing the samples.  A separate needle was inserted through the rubber septum of 





sample tubes fitted with a

















Table 3: Syncronized L4 larvae exhibit significant levels of specific heme 
staining when stained under deoxygenated conditions. 
Synchronized L1 larvae from wild-type worms grown in mCeHR medium and 20 µM 
heme were inoculated in mCeHR medium, supplemented with 1.5 µM, 4 µM, 20 µM, 
and 40 µM heme until they reached the L4 stage.  The synchronized L4s were fixed, 
permeabilized, and stored overnight as described in Materials and Methods.  
Approximately 15 h later, the worms were stained for heme under deoxygenated 
conditions described in Materials and Methods.  All experimental samples had > 80 
% specific heme staining. 
 
 
[heme] Percent of worms that stained 
within each group 
 Control Experimental 
1.5 µM  0 % > 80 % 
4.0 µM  0 % > 80 % 
20 µM ~ 5  % > 80 % 






Figure 7: Synchronized L4 larvae grown at 1.5 µM, 4 µM, 20 µM, and 40 µM 
heme and stained for heme under deoxygenated conditions. 
Wild-type worms were grown in 20 µM heme and mCeHR medium.  Their eggs were 
harvested by bleaching and hatched overnight in M9 buffer as described in Materials 
and Methods.  The synchronized L1 larvae were then inoculated in mCeHR medium 
supplemented with 1.5 µM, 4 µM, 20 µM, and 40 µM heme and allowed to develop 
to the L4 stage.  The synchronized L4 worms were fixed, permeabilized, and stored 
overnight as described in Materials and Methods.  The larvae grown at 40 µM heme 
had the most intense staining of all the experimental samples, while the difference in 
heme staining intensity between 1.5 µM, 4 µM, and 20 µM was not significant.  This 
experiment was performed one time and each micrograph is a representative image.  











The experimental samples from the worms grown at 1.5 µΜ heme exhibited staining 
that was not significantly different from staining of experimental worm samples from 
4 µM and 20 µM heme.  The difference in staining intensity between 4 µM, and 20 
µM larvae was not as great as the difference between either of those groups and 40 
µM (Figure 7).  
Mixed population of worms grown at 1.5 µM, 4 µM, 20 µM, and 40 µM heme  
We were able to drastically reduce the non-specific staining in our control samples by 
incubating the worms in a CAT/SOD solution and staining the worms under 
deoxygenated conditions.  We then decided to stain mixed populations of worms to 
determine if deoxygenated conditions would reduce the non-specific staining in 
gravids in the control groups.  Mixed populations of worms were grown in 1.5 µM, 4 
µM, 20 µM, or 40 µM heme, then fixed, permeabilized, and stored overnight as 
described in Materials and Methods.  The worms were then stained for heme as 
described in Materials and Methods.  
As shown in Table 4, > 80.0 % of gravid worms in the control group stained, 
and the larvae in this group showed minimal levels of non-specific staining.  Based 
on these results and results from previous experiments, we decided to use 
synchronized non-gravid worms for future staining. To determine the optimal time for 
analysis, the stained worms were analyzed either immediately or the following day.  
Optimal results were obtained when samples were analyzed the same day the staining 





Table 4: Differences in specific heme staining between larval and gravid worms 
at 1.5 µM, 4 µM, 20 µM, and 40 µM heme. 
Mixed populations of worms were grown in mCeHR medium and 1.5 µM, 4 µM, 20 
µM, or 40 µM heme.  They were permeabilized, fixed, and stained for heme as 
described in Materials and Methods.  For gravid worms, there was no difference in 
staining between experimental and control groups.  Larval worms, however, exhibited 
significant levels of specific heme staining.   
 
                               Percentage of worms that stained within each sample 
[heme] Control Experimental 
 Gravids Larvae Gravids Larvae 
1.5 µM > 80 % < 1 % 100 % ~ 80 % 
4 µM 100 % ~ 5 %  100 % ~ 70 % 
20 µM > 90 % < 1 % 100 % ~ 60 % 






Standardization of necessary SOD concentration  
In order to determine the optimal staining conditions, we used varying levels of SOD 
(0.02 %, 0.06 %, 0.1 %, 0.15 % and 0.2 %).  While we were trying to establish the 
minimum concentration of SOD required to minimize staining in our control samples, 
there were additional results from this experiment.  We were able to determine that a 
concentration of 0.02 % SOD sufficiently minimized non-specific staining; less than 
10 % of the worms in the control samples stained.  We also observed, for the first 
time, distinct, punctate intestinal heme staining in the experimental groups.  Two 
punctate staining patterns were observed.  Punctate staining seen outside the intestine 
(Figure 8A and 8B) or in the intestine (Figure 8C and 8D).   
 One other observation we noted throughout all of our heme staining 
experiments was that the majority of heme staining was concentrated in the anterior 





Figure 8: Intestinal punctate staining. 
Wild-type worms were grown in 20 µM heme in axenic mCeHR medium.  Their 
progeny was synchronized and grown in mCeHR medium containing 4 µM heme. 
The worms were harvested at the mid-L4 stage, fixed, permeabilized, and stored 
overnight as described in Materials and Methods.  Approximately 15 -18 h later, the 
worms were stained for heme as described in Materials and Methods.  Two punctate 
heme staining patterns were observed.  One pattern showed heme staining outside the 
intestine (A and B), while the other pattern exhibited heme staining within the 
intestinal cells (C and D).  The arrows within each of these figures indicate the 
punctate staining. This experiment was performed one time and each micrograph is a 













Figure 9: Heme absorption in intestinal cells. 
Larval worms were grown in 1.5 µM heme, harvested, fixed, and permeabilized as 
described in Materials and Methods.  Approximately 15 h later, these worms were 
stained for heme as described in Materials and Methods.  The heme staining signal 
was most intense in the anterior intestinal cells and decreases in intensity until there is 











Chapter 4: Application of new heme staining technique  
 
Summary  
We have developed and optimized a methodology to histochemically detect in 
situ heme under normal physiological conditions in C. elegans.  We applied this heme 
staining protocol in three capacities: to evaluate qualitative differences in heme levels 
and localization between the mutant and wild-type worms, to explore the possibility 
that the maternal heme effect in C. elegans could be visualized by staining, and to 
continue heme staining studies of wild-type worms at the electron microscopy (EM) 
level.  Our research group identified 13 strains of C. elegans mutant in heme 
homeostasis and 5 of these mutant strains were selected for this heme staining study. 
We show that all but one of the five mutants selected exhibit less intense heme 
staining than wild-type.  We then tested possible heme staining differences caused by 
the maternal heme effect.  A maternal effect occurs when the offspring phenotype is 
due solely to substances directly passed to the offspring from the mother, whether the 
substances are mRNA, proteins, or other molecules, such as heme.  Results from this 
experiment show that C. elegans progeny of wild-type worms grown in different 
heme concentrations stain differently for heme.  Finally, to more precisely locate 
heme within individual cells, we applied our heme staining technique to EM 
experiments in order to characterize heme staining at the ultrastructure level in C. 
elegans.  In each of these experiments, we experienced issues with non-specific 





conclusions about heme localization in C. elegans at the EM level.  However, these 
results also indicated that heme staining C. elegans at the level of the light 
microscope provides a starting point from which to examine heme uptake and 
localization at the ultrastructure level. 
Rationale  
We hypothesize that heme homeostasis is mediated by specific molecules.  To 
identify the genetic determinants of heme, a forward genetic screen conducted in our 
research group obtained thirteen strains of worms mutated in heme homeostasis.  
Phenotypically, these worms are capable of surviving in 800 µM or 1 mM 
concentrations of heme, levels that are toxic to wild-type worms.  In principle, these 
mutants could differ from wild-type worms in that the heme transport pathway(s) 
either transport less heme into intestinal cells, sequester heme more efficiently, or 
more rapidly detoxify heme.  In order to further understand heme transport in C. 
elegans, we utilized our heme staining technique and compared differences in heme 
levels between the mutant and wild-type worms grown at low concentrations of 
heme.  
A maternal effect occurs when the source of an offspring phenotype is due 
solely to substances including mRNA, androgens or other compounds that are passed 
on to the offspring by the mother.  This phenomenon has been characterized in wasps, 
birds, and humans (61-64) and most importantly, in C. elegans, involving proteins 
such as phosphatase, isomerase, and CDK (65,66).  C. elegans requires heme for 





maternal substances to the progeny is vital to their embryonic growth and 
development led us to postulate that maternal heme might also be passed on to 
progeny.  Furthermore, while C. elegans is a non-parasitic nematode, there are several 
known parasitic nematodes that are also heme auxotrophs.  It is possible that the 
maternal proteins responsible for transferring heme to the embryos could potentially 
be drug targets to limit these parasitic infections (13).  Unpublished data have shown 
that when F1 larvae obtained from P0 worms that were grown in low (4 µM), optimal 
(20 µM), and high (500 µM) heme were inoculated into medium containing no added 
heme, F1 progeny of the worms grown at 4 µM heme growth arrested at the L3 larval 
stage, while the F1 progeny of the worms grown at 500 µM growth arrested as early 
adults.  These results suggested that heme levels available to the mother affected the 
subsequent growth and development of her offspring.  We therefore examined 
differences in heme staining intensity and localization between the progeny of worms 
grown at 4 µM, 20 µM, and 500 µM heme.  
Previous work conducted to study eukaryotic heme uptake and localization at 
the ultrastructure level used abnormal, non-physiological conditions of heme-loading 
in organisms that synthesize heme.  One of these studies designed to characterize 
heme uptake in the rat duodenum at the EM level used heme administered to rats as 
hemoglobin or hemin chloride in highly concentrated quantities through an 
intragastric tube (7).  Administration of high quantities of hemoglobin/hemin chloride 
is abnormal as well as non-physiological.  We have standardized a technique to stain 





auxotroph C. elegans.  It is our goal to apply this heme staining technique in EM 
experiments in order to characterize heme localization in wild-type worms.  Using C. 
elegans allows us to completely control the concentration of heme available to the 
animal.  Additionally, the location of every one of its 959 somatic cells is the same in 
every animal, allowing us to precisely identify heme localization in each cell.  
Furthermore, the entire worm has been sectioned and the images are available online 
at www.wormimage.org to use as a reference for characterizing where cellular heme 
is located.  
 Results 
Worms mutated in heme homeostasis display differential heme staining as 
compared to wild-type worms.  
 
An unpublished study was conducted using random EMS-based mutagenesis in C. 
elegans to identify mutants resistant to toxic heme levels (800 µM).  Dr. Anita Rao 
isolated 13 mutants which belong to 5 complementation groups (Table 5).  The 
rationale for characterizing these mutants for heme staining is that disruption in heme 
homeostasis by either heme transport or heme sequestration would lead to survival 
under toxic heme levels.  Thus, the logical extension for our studies would be to 
examine how much and where heme localized in these mutants at the level of the 
light microscope.  For this experiment, we analyzed one mutant from each 
complementation group, as indicated in Table 5.  The experiment was conducted 
twice and the results are summarized in Tables 6 and 7.  There was no staining 
observed in worms from the control groups (Table 6).  Only 50 % of the worms in 





punctate, and restricted to the first 5 pairs of intestinal cells.  Mutant worms IQ731, 
IQ938, IQ828, IQ911 had less intense heme staining than wild-type.  However, 
IQ911 revealed the lowest intensity in the punctate staining than any of the other 
mutants (Figure 10).  In contrast to the other four mutants, IQ1068 revealed an 
increase in staining intensity compared to wild-type worms. 
Progeny obtained from worms grown at different heme levels stain differentially 
for heme. 
Wild-type worms were grown for at least two generations in 4 
µΜ, 20 µΜ, and 500 µΜ heme.  Their eggs were harvested, synchronized overnight 
in M9 buffer.  The following morning, the synchronized larvae were inoculated into 
mCeHR medium with no added heme, and allowed to grow for six days.  On day 6, 
there were no visible gravid worms by microscopic examination in each of the three 
groups.  However, there were notable differences in their developmental stage. F1 
progeny from 4 µM heme were growth arrested at the L3 stage while F1 progeny from 
the 500 µM heme were arrested at the early adult stage.  F1 progeny from 20 µM 
growth arrested at the early L4 stage.  The difference in growth rates of these worms 
is summarized in Table 8. The progeny were then histochemically stained for heme as 
described in the Materials and Methods section.  No staining was observed in any of 
the samples in the control groups.  The larvae that stained the most intensely for heme 
were from the progeny of worms grown at 500 µM heme (Figure 11).  The larvae 
from worms grown at 20 µΜ heme stained less than half as intensely as the progeny 
of the worms grown at 500 µM heme.  Heme staining in larvae obtained from worms 





Table 5: Complementation groups of heme-resistant mutant worms. 
The thirteen mutants resistant to high heme are grouped in 5 complementation groups  
[courtesy of Dr. A. Rao and B. Le].  Mutants selected to analyze by heme staining are 




Mutants in each complementation group 
I  IQ911     
II  IQ828     
III  IQ728 IQ938 IQ968   
IV  IQ921 IQ718 IQ731   
V  IQ1058 IQ1048 IQ1068d IQ1031 IQ1068 






Table 6: Percent of specific heme staining in wild-type worms and worms 
mutated in heme homeostasis. 
N2, IQ938, IQ731, IQ911, IQ828 and IQ1068 worms were grown in mCeHR medium 
with 4 µM heme.  F1 embryos were harvested, synchronized, and inoculated at 4 µM 
heme.  When they reached the mid-L4 stage, they were stained for heme as described 
in Materials and Methods.  There was no staining in worms from the control groups.  
In worms from the experimental groups, only 50 % of the worms showed heme 





N2 0 % 50 % 
IQ938 0 % 50 % 
IQ731 0 % 50 % 
IQ911 0 % 50 % 
IQ828 0 % 50 % 






Table 7: Heme resistant mutants reveal differential heme staining. 
The mutant worm strains IQ828, IQ938, and IQ938 all exhibited staining that was 
slightly less intense than wild-type, while IQ911 heme staining was significantly less 
intense than wild-type.  Only one strain, IQ1068, exhibited heme staining that was 




Relative intensity compared between wild-type and mutant 
I N2 >> IQ911 
II N2 ≥ IQ828 
III N2 ≥ IQ938 
IV N2 ≥ IQ731 






Figure 10: Heme staining wild-type, IQ731, IQ911, IQ828, IQ1068, and IQ938 
strains grown at 4 µM heme. 
Wild-type, and mutant strains IQ731, IQ911, IQ828, IQ1068, and IQ938 were grown 
in 4 µΜ heme in mCeHR medium for two generations.  Their eggs were harvested 
and hatched overnight in M9 buffer. The synchronized L1 larvae were inoculated into 
4 µM heme in mCeHR medium.  When the worms reached the mid-L4 stage, they 
were fixed, permeabilized, and stored overnight as described in the Materials and 
Methods section.  Approximately 15 – 18 h later, the worms were stained for heme 
using the protocol described in the Materials and Methods section.  This experiment 
was performed two times and each micrograph is a representative image.  Scale bar = 

















Table 8: Maternal heme effect on growth rates of progeny obtained from 
parental worms grown at different heme concentrations. 
F1 progeny of worms grown at 4 µM, 20µM, and 500µM heme were grown in 
mCeHR medium with no added heme for six days.  After 24 h, the F1 progeny of 
worms grown at 4 µM heme had reached the L3 larval stage, the stage at which their 
growth was arrested.  F1 progeny of worms grown at 20 µM heme reached the mid-L4 
stage after 49 h, after which they developed no further.  The F1 progeny of worms 
grown at 500 µM heme reached the early adult stage after 94 h and did not ever 
become gravid.  ND = not detected. 
 
[Heme] 
available to P0 
worms 
Time required for F1 progeny to reach growth stages  
 
       L3                 Early L4               Mid-L4              Early adult 
     
4µΜ  24 h ND ND ND 
20µΜ  24 h 40 h 49 h ND 






Figure 11: Progeny obtained from worms grown at different heme levels reveal a 
maternal heme effect. 
Wild-type worms were grown for at least two generations in 4 µM, 20 µM, or 500 
µM heme.  Gravid worms were bleached, and their eggs were harvested and 
synchronized overnight in M9 buffer as described in Materials and Methods.  
Synchronized L1 larvae were inoculated into separate flasks of mCeHR medium with 
no added heme.  After 6 days, the worms were harvested, fixed permeabilized, and 
stained as described in Materials and Methods.  Heme staining in larvae obtained 
from worms grown at 4 µΜ heme was barely detectable.  The larvae from worms 
grown at 20 µΜ heme stained less than half as intensely as the progeny of the worms 
grown at 500 µM heme. The larvae that stained the most intensely for heme were 
from the progeny of worms grown at 500 µM heme.  The arrow bars indicate heme 
staining.  This experiment was performed five times and each micrograph is a 













Preliminary results of heme staining C. elegans at the ultrastructure level  
 
For the electron microscopy studies we needed to modify the permeabilization and 
fixation protocol.  C. elegans has a cuticle that is tough to penetrate by standard 
fixation and permeabilization methods.  One permeabilization and fixation method 
available for C. elegans which allows for preservation of tissue integrity at the 
ultrastructure level is microwave fixation (57)  Personal instructions were provided 
by Dr. David Hall, the Director of the Center for C. elegans Anatomy at the Albert 
Einstein College of Medicine.  Microwave energy increases the rate at which fixative 
solutions penetrate the cuticle and subsequent underlying tissues.  Additionally, this 
fixation method improves the penetration of resin, the embedding material, without 
any further exposure of the sample to the microwave energy (57).  The previous 
chemical method provided sufficient permeabilization of the cuticle for heme staining 
analysis at the light microscopy level.  However, preservation of the tissue structure 
was insufficient for analysis at the ultrastructural level (Figure 12). 
We standardized the microwave fixation protocol in order to sufficiently 
preserve subcellular structures while simultaneously ensuring that heme staining can 
be observed at the ultrastructure level in C. elegans.  Modifications were made to a 
previously published protocol (57) with personal communication from Dr. Hall.  
DAB is the chromogenic substrate of choice because it has a distinct, 
localized electron dense reaction product.  Furthermore, it has been shown that the 
reaction product of the compound may not be affected by the embedding process 





concentration of DAB for microwave fixation because microwave fixation is not as 
penetrative as the chemical fixation that was used previously.   Our first experiment 
tested three concentrations of DAB: 0.15 %, 0. 30 %, and 0.45 %.  We stained 
synchronized L4 larvae that had been grown at 20 µM heme in mCeHR medium.   
The best results were obtained with worms with 0.15 % DAB, although there was 
very light staining in ~ 30.0 % of the worms from the control group.  The two higher 
concentrations of DAB produced high staining (>50.0 %) in the control group.  The 
tissue structure preservation, however, was superior to the previously used chemical 
fixation and permeabilization method as shown in Figure 12.  We were satisfied with 
the preservation of tissue structure when observed under a light microscope, and 
proceeded with our EM studies.   
Once we established the microwave fixation and heme staining protocols, we 
conducted a few electron microscopy studies to standardize the dehydration and 
embedding method given to us by Dr. Hall.  As a first step, we decided to do the EM 
experiments with wild-type worms grown to mid-L4 stage in 80 µM heme.  We chose 
to stain worms grown at 80 µM heme because we reasoned we would be able to see a 
greater heme staining signal without subjecting the worms to physiological toxic 
levels of heme.  Mid-L4 larvae were harvested, fixed, and permeabilized by 
microwave fixation as described in the Materials and Methods section, and stained for 
heme using the DAB staining protocol previously standardized by us for light 
microscopy.  This was followed by further fixation and counterstaining by osmium 





Figure 12: Comparison of microwave fixation to chemical fixation. 
Synchronized wild-type L1 larvae were grown in 20 µM heme until they reached the 
mid-L4 stage.  The L4 larvae were harvested, fixed, and permeabilized by microwave 
fixation as described in the Materials and Methods section.  The same day, these 
worms were stained for heme.  Permeabilization and fixation by microwave fixation 
showed substantially improved cellular structure preservation as compared to earlier 
studies using chemical fixation.  This experiment was performed one time and each 












epoxy resin, thin–sectioned, placed on copper grids, and examined under EM, as 
described in the Materials and Methods section. Prior to the embedding process, 
worms are fixed and counterstained with osmium tetroxide.  After the worms have 
been embedded and thin sectioned, the thin sections of tissue are further 
counterstained with lead citrate and uranyl acetate.  To standardize counterstaining 
conditions of lead citrate and uranyl acetate, we based our first round of 
standardizations on the recommendation from Dr. Hall.  We first tested multiple time 
points of lead citrate staining 1, 1.5 and 2 min and uranyl acetate time points at 10, 
15, 20, and 25 min.  There were no significant differences in electron dense spots 
between control and experimental samples.  These results suggested the possibility 
that the counterstains may interfere with the visualization of heme.  We decided to 
omit counterstaining with lead citrate because it was more likely to precipitate on the 
grid.  To standardize the uranyl acetate counterstaining we incubated the grids for 0, 
6, 8, and 10 min time points to determine the minimum counterstaining required to 
visualize the tissue using EM.  After trying to standardize this round of 
counterstaining, we were still not seeing significant differences between control and 
experimental samples. We decided to counterstain using only osmium tetroxide to 
minimize the possibility of counterstaining precipitate.  
Experiments were conducted with wild-type worms grown to the mid-L4 
stage in 80 µM heme.  The results from these two studies were inconclusive. When 
DAB is oxidized by hydrogen peroxide, it leaves a well-characterized, easily 
identifiable dark, electron dense precipitation product.  Images from the two identical 





control and experimental samples.  
Sections from nine different worms in the first experimental group were 
evaluated.  The images taken were of the worm intestine.  Present in these samples 
were storage granules that, because of their electron dense appearance, they were 
initially mistaken for possible heme containing vesicles, indicated by asterisks in 
Figure 13.  However, upon examination of other C. elegans EM images, we 
determined that these vesicles were not heme.  These structures are most likely to be 
gut granules described as having an electron dense appearance because of the various 
compounds they contain including carbohydrates, lipids and proteins (yolk granules), 
or concentrated waste products  (www.wormatlas.org).  These gut granules were 
present in both groups of worms incubated with DAB (controls and stained), as well 
as in a control group incubated in the absence of DAB.   
In these experiments there were electron dense spots that caught our attention, 
but their presence in both control and stained groups led to the conclusion that we 
could not analyze the electron dense spots as heme staining.  These spots varied in 
number, size and shape.  A few sections from the experimental samples had as many 
as twelve dense spots, while others had only one or two.  In the control samples, there 
was an average of 4-5 electron dense spots.  Most of these spots were irregularly 
shaped and varied in size but sections from both experimental and control samples 
had an average number of about five irregularly shaped, electron dense spots (Figure 





Figure 13: Wild-type worms grown at 80 µM heme, histochemically stained for 
heme, and examined at the ultrastructural level. 
Wild-type worms (P0) were grown at 80 µM heme.  Their eggs were harvested by 
bleaching, and synchronized overnight in M9 buffer.  The following morning, the 
synchronized L1 larvae were inoculated into 80 µM heme in mCeHR medium.  When 
the larvae reached the mid-L4 stage, they were processed for EM as described in the 
Electron Microscopy section of Materials and Methods.  The arrows depict DAB 
staining observed in control and experimental samples.  Asterisks depict gut granules. 
This experiment was performed three times and each micrograph is a representative 
















These electron microscopy experiments contained two different controls.  The first 
control was incubated with DAB only, while the second control was incubated in the 
absence of DAB.  Sections from the first control group contained 2-5 of the 
irregularly shaped, electron dense spots seen in the stained group of worms.  Sections 
from worms incubated in the absence of DAB were examined and none of these 
sections had the irregularly shaped electron dense spots observed in the control 
samples incubated with DAB only (-H2O2).  This suggested that there was non-
specific DAB staining in our first (DAB only) control group.  In conclusion of this 
series of experiments, comparisons between stained and control samples revealed 
areas of the cell with dark precipitate, presumably DAB staining.  The precipitate 
spots were non-uniform in size, shape, and number per worm section (Figure 13) and 
could not be attributed to lead citrate or uranyl acetate because we did not 
counterstained the sections with these compounds.  
Discussion  
C. elegans is a natural heme auxotroph but relies on exogenously supplied 
dietary heme for metabolic functions.  In the current study, we have established an in 
situ heme staining protocol for whole animals using C. elegans.  While directly 
staining animal tissues for heme has been conducted for more than 20 years (7,8,54), 
to our knowledge, the ability to microscopically examine heme uptake and 
localization in an intact, genetically tractable animal under physiologic conditions of 
nutritional heme levels had not been accomplished.  Additionally, we describe a 






Heme staining studies conducted on a heme auxotroph, the cattle tick 
Boophilus microplus, showed that this animal contains a specialized organelle called 
a “hemosome” for sequestration of large quantities of heme that this insect ingests 
(54).  However, these studies were not corroborated with histochemical staining of 
heme in the intact tissue.  Engorged ticks were dissected, and their midgut tissues, not 
their whole bodies, were stained for heme.  Isolating and staining tissues from whole 
animals to study heme has been a standard practice for previous staining studies (7,8).  
Additional studies using digest cells of the tick and fluorescent porphyrin derivatives, 
of the tick the cattle tick showed heme transport in the cell (15).  Unlike cattle ticks, 
C. elegans is translucent, making it ideal for cytological heme localization studies 
using light microscopy. 
Establishing the methodology described herein took considerable time and 
effort as DAB, the chromogenic substrate used to localize heme, reacts with 
endogenous oxygen radicals to produce significant levels of staining in the samples 
from the control group with pre-incubation with SOD and CAT, we found that heme 
staining in C. elegans is does dependent  (Figure 7).  Furthermore, phylogenetically 
diverse nematodes, especially several species of parasitic nematodes, do not 
synthesize heme (13).  This heme staining technique could provide valuable 
information on heme uptake, sequestration, and localization in nematodes. 
Through the standardization process, we observed that eggs in gravid worms 
revealed considerable DAB reactive product in the control group.  Furthermore, 





between gravid embryos of the control and experimental samples.  Plausibly, , during 
during fixation and permeabilization steps, the embryo eggshell was sufficiently 
permeabilized to permit DAB entry (mw = 214 g/mol) but did not allow sufficient 
access to larger molecules, SOD (mw = 32.5 kDa for the dimer) and CAT (mw = 250 
kDa for the tetramer).  Based on these observations, we decided to focus on 
synchronized L4 larvae for future studies.  We chose the L4 larval stage because this 
is the developmental stage at which the intestine of the worm is fully developed but 
embryogenesis has not yet begun, thus providing us with sufficient information 
regarding heme transport without confounding results due to variations in tissue 
permeabilization.  
 We also established a connection between the concentration of heme in the 
growth medium and the intensity of the heme staining observed in the worms.  With 
the exception of worms grown at 1.5 µM heme, the higher the concentration of heme 
in the medium, the more intensely the worms stained for heme.  The largest 
difference in staining intensities were observed between worms grown at 20 µM and 
100 µM heme as well as between worms grown at 4 µM and 40 µM heme.  
Interestingly, in the second experiment, the group of worms grown in 1.5 µM heme 
stained more intensely than expected.  Plausibly, under limiting heme conditions, 
heme uptake must be maximized to sustain normal growth and development.  Indeed, 
unpublished microarray and qRT-PCR results suggest that a significant proportion of 
heme responsive genes (hrg’s) are highly upregulated at 1.5 µM compared to 4 µM or 





The differences in staining patterns between worms in earlier and worms of 
later experiments should also be addressed.  Worms stained in earlier experiments 
exhibited uniform staining throughout their bodies.  The punctate staining was 
observed in worms only in later experiments. There are several explanations for 
punctate staining, each involving the possible ways in which heme is absorbed into 
the intestinal cells.  One possibility is that heme is absorbed by endocytosis.  Heme 
contained within a vesicle formed by endocytosis, could cause the reaction that 
oxidizes DAB, therein, leaving localized punctate staining.  Another explanation for 
the punctate staining involves a specialized vesicle into which heme is transported 
after it has been absorbed into the cell.  Heme contained within this could also cause 
punctate staining. 
There were two patterns of punctate staining: one which showed punctate 
staining outside the intestinal lumen, presumably concentrated within the intestinal 
cells, while the second pattern was punctate staining that appeared to be outside the 
intestinal cells.  Although it is expected that heme will be located in both of these 
places, it is unclear why the punctate staining would remain segregated.  Perhaps this 
is the limitation of using fixed versus live worms.  
Another difference to note and further explore is the localization of punctate 
staining.  Consistently, there was heavier staining in the anterior half of the intestine 
that faded gradually until there was virtually no detectable staining in the posterior 
cells.  We speculate that the anterior intestinal cells may be the primary location for 
heme import and uptake in C. elegans.  Consistent with this notion, the anterior 





membrane-bound organelles and vacuoles, while the posterior portions are active in 
energy storage, e.g., yolk and lipid vacuoles.  Thus the differences we observe with 
heme staining throughout the intestine may reflect the difference in heme absorption 
intrinsic to C. elegans (Figure 9).  Furthermore, corroborating evidence supporting 
this data was obtained using Raman confocal microscopy.  
Differences in the histochemical heme staining among the mutants, as well as 
between the mutant and wild-type worms, suggest that these mutants may have 
differences in quantitative levels of heme.  Each of these mutant strains of worms was 
selected as a representative strain from each of the 5 complementation groups. 
Whether these are qualitative differences in the precise location of the punctate 
staining cannot be addressed at the light microscopy level.  One heme staining 
consistency between the mutant and wild-type worms was that the punctate staining 
in the mutants was consistently restricted to the first 5 pairs of cells in the anterior 
region of the intestine.  
It is also important to note that even though worms from each of the five 
complementation groups were isolated based on heme resistance, IQ911 and IQ1068 
showed opposite levels of heme staining compared to wild-type worms.  IQ911 
consistently showed less heme staining while IQ1068 showed more intense heme 
staining than wild-type.  Furthermore, IQ938, IQ731, and IQ828 all showed heme 
staining that was slightly less than wild-type worms.  It is currently not known how 
these animals are capable of surviving in concentrations of heme that are otherwise 
toxic to wild-type worms, but there are several conceivable explanations.  One 





IQ938, IQ728, and IQ828, is that these worm strains contain mutations in heme 
transporter machinery, resulting in import of less heme thus preventing the 
accumulation of toxic concentrations of intracellular heme.  While IQ938, IQ731, and 
IQ828 all had growth rates similar to wild-type, the IQ911 strain consistently grew 
slower than wild-type by approximately 12 – 15 h.  This observation is consistent 
with the notion that this strain reveals lower heme staining compared to wild-type 
worms. Conversely, strain IQ1068 showed slightly increased heme staining as 
compared to wild-type worms, possible because this mutant can detoxify or sequester 
heme differently than wild type.  Taken together, future studies will be needed to 
address the biological mechanism for the observed differences in heme staining 
intensity in these mutants.  Staining patterns and intensities in these mutants will be 
further characterized using heme analogs, RNA interference and heme reporter sensor 
strains.   
C. elegans reveals a maternal effect for heme that is demonstrated by 
differences in growth and development, as well as in the intensity of histochemical 
heme staining.  The differences in staining between the three experimental groups of 
worms were distinct.  The likely sources of these differences are the levels of heme 
available to the parent and the amount of heme transported to the progeny during 
embryogenesis.  Notably, the progeny with the highest level of heme, that reached the 
most advanced stage of development, never became gravid.  Presumably, progeny 
from 500 µM worms had sufficient heme to undergo development to reproductive 
fitness, but initiation of embryogenesis must require heme levels greater than what 





could be supplied with sufficient heme to undergo embryogenesis, if the P0 
generation was grown at concentrations of heme > 500 µM, we found that this was 
not likely to be the case.  Heme concentrations ≥ 800 µM are toxic to wild-type 
worms, and the worms growth arrest at the L3 stage (13).  Future maternal heme 
experiments could be conducted with mutants to address whether or not the heme 
resistant mutations have any effect on the progeny phenotype.   
Finally, we provide a framework and preliminary results for future 
ultrastructural heme localization studies in C. elegans.  While there are a few 
problems that need to be first addressed and optimized prior to continuing EM 
studies, the implications for studying heme uptake and localization at the EM level 
using C. elegans, could have a significant impact in heme transport studies.  There are 
numerous advantages to studying heme uptake in C. elegans at the ultrastructural 
level.  First, C. elegans is a natural heme auxotroph that will have no endogenous 
heme to confound results.  Another advantage is that the entire cell lineage of C. 
elegans has been mapped, and the location and number of all somatic cells does not 
vary between individual animals.  Furthermore, there are thousands of unpublished 
EM images of C. elegans available on the World Wide Web, at 
www.wormimage.org.  Many of these images contain labels identifying different 
cells and cellular structures, providing an invaluable tool for heme localization in 
specific cell types.  Previously published studies of heme uptake at the electron 
microscopy level used animals that are heme prototrophs (7,8) and were conducted 
either under abnormal physiological conditions (7) or with radiolabeled heme (8)  Our 





to pursue heme staining studies at the EM level.  However, the conditions to observe 
heme at the ultrastructural level have to be optimized.  Microwave fixation and heme 
staining using DAB produced good results at the light microscopy level.  However, it 
is obvious that 30 % of staining in the control group, even though the staining was 
extremely light, confounded our results at the EM level.  The following steps will 
need to be optimized: Establish a microwave fixation protocol that gives high 
permeabilization of worms without compromising the quality of the anatomical and 
morphological structure.  This will permit the DAB to penetrate better at much lower 
concentration and for shorter incubation times such that worms from the control 
group give < 5 % visible staining.  Levels of tissue preservation were also varied, so 
it is quite possible that reducing the time of exposure and controlling energy levels of 
the microwaves will improve the tissue structure at the ultrastructure level.  This 
standardization will take a considerable amount of time because at each step the 
samples need to be examined at the ultrastructural level.  Taken together, our studies 
suggest that individual parameters will have to be further optimized to adapt our 
histochemical in situ staining for heme at the light microscopy level to better preserve 
tissue and lower non-specific staining at the ultrastructural level for EM.  Once these 
issues have been addressed, electron microscopy experiments will provide a powerful 
tool to further advance our knowledge and understanding of heme uptake and 
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